Trump's remarks about a specific malaria drug he said had shown promise at treating the COVID-19 disease were quickly contradicted by his own Food and Drug Administration (FDA) commissioner, suggesting the president's optimism might have been outrunning the reality on the ground.
Trump said a drug used to treat malaria is showing promise at treating COVID-19, the disease caused by the coronavirus, and would be available “almost immediately.”
“It is known as a malaria drug and it’s been around for a long time and it’s very powerful,” Trump said. “But the nice part is it’s been around for a long time so we know if things don’t go as planned, it’s not going to kill anybody.”
Those remarks were at odds with those of his FDA commissioner, Stephen Hahn, who shortly later repeatedly emphasized the importance of safety and said he does not want to “provide false hope.”
“We may have the right drug, but it might not be in the appropriate dosage form right now, and it might do more harm than good,” Hahn said.